GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population

Cancer Letters

Volumn 201, Issue 2, 2003, Pages 185-193

  Wang, Jingwen ^a   Deng, Yifu ^a   Cheng, Jinglei ^a   Ding, Jianmin ^a   Tokudome, Shinkan ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Genetic polymorphism; Glutathione S transferases; Lung adenocarcinoma; Susceptibility

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINA; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0242289468     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00480-4     Document Type: Article

References (54)

1. Hoffmann D., Rivenson A., Hecht S.S. The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. Crit. Rev. Toxicol. 26:1996;199-211.
2. Charloux A., Quoix E., Wolkove N., Small D., Pauli G., Kreisman H. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int. J. Epidemiol. 26:1997;14-23.
3. Oyama T., Kagawa N., Kim Y.D., Matsumoto A., Isse T., Kawamoto T. Lung cancer and CYP1A1 or GSTM1 polymorphisms. Environ. Health. Prev. Med. 7:2003;230-234.
4. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30:1995;445-600.
5. Mannervik B. The isoenzymes of glutathione transferase. Adv. Enzymol. Relat. Areas Mol. Biol. 57:1985;357-417.
6. Eaton D.L., Bammler T.K. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol. Sci. 49:1999;156-164.
7. Ali-Osman F., Akande O., Antoun G., Mao J.X., Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J. Biol. Chem. 272:1997;10004-10012.
8. Watson M.A., Stewart R.K., Smith G.B., Massey T.E., Bell D.A. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 19:1998;275-280.
9. Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ. Health Perspect. 107:(Suppl. 1):1999;37-47.
10. Terrier P., Townsend A.J., Coindre J.M., Triche T.J., Cowan K.H. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am. J. Pathol. 137:1990;845-853.
11. Anttila S., Hirvonen A., Vainio H., Husgafvel-Pursiainen K., Hayes J.D., Ketterer B. Immunohistochemical localizaton of glutathione S-transferases in human lung cancer. Cancer Res. 53:1993;5643-5648.
12. Saarikoski S.T., Voho A., Reinikainen M., Anttila S., Karjalainen A., Malaveille C., Vainio H., Husgafvel-Pursiainen K., Hirvonen A. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int. J. Cancer. 77:1998;516-521.
13. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat. Res. 463:2000;247-283.
14. Harries L.W., Stubbins M.J., Forman D., Howard G.C., Wolf C.R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 18:1997;641-644.
15. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Ogreid D., Ulvik A., Vu P., Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289.
16. Wang J., Deng Y., Li L., Kuriki K., Ding J., Pan X., Zhu-Ge X., Jiang J., Luo C., Lin P., Tokudome S. Association of GSTM1, CYP1A1 and CYP2E1 polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population. Cancer Sci. 94:2003;448-452.
17. Blin N., Stafford D.W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3:1976;2303-2308.
18. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., Ketterer B., Taylor J.B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300:(Pt 1):1994;271-276.
19. Seidegard J., Vorachek W.R., Pero R.W., Pearson W.R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. USA. 85:1988;7293-7297.
20. Lum A., Le Marchand L. A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. Cancer Epidemiol. Biomarkers Prev. 7:1998;719-724.
21. Lan Q., He X., Costa D.J., Tian L., Rothman N., Hu G., Mumford J.L. Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. Cancer Epidemiol. Biomarkers Prev. 9:2000;605-608.
22. Setiawan V.W., Zhang Z.F., Yu G.P., Lu Q.Y., Li Y.L., Lu M.L., Wang M.R., Guo C.H., Yu S.Z., Kurtz R.C., Hsieh C.C. GSTP1 polymorphisms and gastric cancer in a high-risk Chinese population. Cancer Causes Control. 12:2001;673-681.
23. Sun G.F., Shimojo N., Pi J.B., Lee S., Kumagai Y. Gene deficiency of glutathione S-transferase mu isoform associated with susceptibility to lung cancer in a Chinese population. Cancer Lett. 113:1997;169-172.
24. Zhao B., Seow A., Lee E.J., Poh W.T., Teh M., Eng P., Wang Y.T., Tan W.C., Yu M.C., Lee H.P. Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol. Biomarkers Prev. 10:2001;1063-1067.
25. Risch A., Wikman H., Thiel S., Schmezer P., Edler L., Drings P., Dienemann H., Kayser K., Schulz V., Spiegelhalder B., Bartsch H. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics. 11:2001;757-764.
26. Stucker I., Hirvonen A., de Waziers I., Cabelguenne A., Mitrunen K., Cenee S., Koum-Besson E., Hemon D., Beaune P., Loriot M.A. Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis. 23:2002;1475-1481.
27. Arai Y., Hirose N., Yamamura K., Nagai M., Jang H., Hattori Y., Ikeda Y. A patient with genetic deletion of glutathione-S-transferase T1 and M1 who developed non-small-cell lung cancer and myelodysplastic syndromes. Am. J. Med. Sci. 318:1999;424-427.
28. Kihara M., Kihara M., Noda K. Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett. 137:1999;53-60.
29. Yamamura K., Kiyohara C., Nakanishi Y., Takayama K., Hara N. Lung cancer risk and genetic polymorphism at the glutathione S-transferase P1 locus in male Japanese. Fukuoka Igaku Zasshi. 91:2000;203-206.
30. Jourenkova-Mironova N., Wikman H., Bouchardy C., Voho A., Dayer P., Benhamou S., Hirvonen A. Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics. 8:1998;495-502.
31. Hayes J.D., Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 61:2000;154-166.
32. Le Marchand L., Sivaraman L., Pierce L., Seifried A., Lum A., Wilkens L.R., Lau A.F. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res. 58:1998;4858-4863.
33. Reszka E., Wasowicz W. Significance of genetic polymorphisms in glutathione S-transferase multigene family and lung cancer risk. Int. J. Occup. Med. Environ. Health. 14:2001;99-113.
34. Alexandrie A.K., Sundberg M.I., Seidegard J., Tornling G., Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis. 15:1994;1785-1790.
35. Ford J.G., Li Y., O'Sullivan M.M., Demopoulos R., Garte S., Taioli E., Brandt-Rauf P.W. Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis. 21:2000;1971-1975.
36. Garcia-Closas M., Kelsey K.T., Wiencke J.K., Xu X., Wain J.C., Christiani D.C. A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States). Cancer Causes Control. 8:1997;544-553.
37. Hayashi S., Watanabe J., Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn. J. Cancer Res. 83:1992;866-870.
38. Kihara M., Noda K., Kihara M. Distribution of GSTM1 null genotype in relation to gender, age and smoking status in Japanese lung cancer patients. Pharmacogenetics. 5:1995;S74-S79.
39. Woodson K., Stewart C., Barrett M., Bhat N.K., Virtamo J., Taylor P.R., Albanes D. Effect of vitamin intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers. Cancer Epidemiol. Biomarkers Prev. 8:1999;965-970.
40. Deakin M., Elder J., Hendrickse C., Peckham D., Baldwin D., Pantin C., Wild N., Leopard P., Bell D.A., Jones P., Duncan H., Brannigan K., Alldersea J., Fryer A.A., Strange R.C. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 17:1996;881-884.
41. Jourenkova N., Reinikanen M., Bouchardy C., Husgafvel-Pursiainen K., Dayer P., Benhamou S., Hirvonen A. Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on lung cancer risk in smokers. Pharmacogenetics. 7:1997;515-518.
42. Salagovic J., Kalina I., Stubna J., Habalova V., Hrivnak M., Valansky L., Kohut A., Biros E. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Neoplasma. 45:1998;312-317.
43. To-Figueras J., Gene M., Gomez-Catalan J., Galan M.C., Fuentes M., Ramon J.M., Rodamilans M., Huguet E., Corbella J. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis. 18:1997;1529-1533.
44. Kelsey K.T., Spitz M.R., Zuo Z.F., Wiencke J.K. Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States). Cancer Causes Control. 8:1997;554-559.
45. Sunaga N., Kohno T., Yanagitani N., Sugimura H., Kunitoh H., Tamura T., Takei Y., Tsuchiya S., Saito R., Yokota J. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol. Biomarkers Prev. 11:2002;730-738.
46. el Zein R., Zwischenberger J.B., Wood T.G., Abdel-Rahman S.Z., Brekelbaum C., Au W.W. Combined genetic polymorphism and risk for development of lung cancer. Mutat. Res. 381:1997;189-200.
47. Harris M.J., Coggan M., Langton L., Wilson S.R., Board P.G. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics. 8:1998;27-31.
48. Miller D.P., Liu G., De,Vivo I., Lynch T.J., Wain J.C., Su L., Christiani D.C. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res. 62:2002;2819-2823.
49. Perera F.P., Mooney L.A., Stampfer M., Phillips D.H., Bell D.A., Rundle A., Cho S., Tsai W.Y., Ma J., Blackwood A., Tang D. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis. 23:2002;1641-1646.
50. To-Figueras J., Gene M., Gomez-Catalan J., Pique E., Borrego N., Carrasco J.L., Ramon J., Corbella J. Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes Control. 10:1999;65-70.
51. To-Figueras J., Gene M., Gomez-Catalan J., Pique E., Borrego N., Corbella J. Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1. Cancer Lett. 173:2001;155-162.
52. Wang Y., Spitz M.R., Schabath M.B., Ali-Osman F., Mata H., Wu X. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. Lung Cancer. 40:2003;25-32.
53. Lewis S.J., Cherry N.M., Niven R.M., Barber P.V., Povey A.C. GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett. 180:2002;165-171.
54. Savige G.S. Can food variety add years to your life? Asia Pac. J. Clin. Nutr. 11:(Suppl. 3):2002;S637-S641.